568 related articles for article (PubMed ID: 19393686)
1. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.
Malone DT; Jongejan D; Taylor DA
Pharmacol Biochem Behav; 2009 Aug; 93(2):91-6. PubMed ID: 19393686
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.
Fadda P; Robinson L; Fratta W; Pertwee RG; Riedel G
Neuropharmacology; 2004 Dec; 47(8):1170-9. PubMed ID: 15567426
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
Zuardi AW; Teixeira NA; Karniol IC
Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
Hine B; Torrelio M; Gershon S
Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):185-8. PubMed ID: 1237925
[TBL] [Abstract][Full Text] [Related]
7. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.
Zuardi AW; Finkelfarb E; Bueno OF; Musty RE; Karniol IG
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):137-46. PubMed ID: 6261703
[TBL] [Abstract][Full Text] [Related]
9. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
Lindamood C; Colasanti BK
J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
[TBL] [Abstract][Full Text] [Related]
10. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
[TBL] [Abstract][Full Text] [Related]
11. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Taffe MA; Creehan KM; Vandewater SA
Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
[TBL] [Abstract][Full Text] [Related]
13. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat.
List A; Nazar B; Nyquist S; Harclerode J
Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525
[TBL] [Abstract][Full Text] [Related]
14. The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus.
Cluny NL; Naylor RJ; Whittle BA; Javid FA
Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):150-6. PubMed ID: 18816298
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
Kolb B; Gorny G; Limebeer CL; Parker LA
Synapse; 2006 Nov; 60(6):429-36. PubMed ID: 16881072
[TBL] [Abstract][Full Text] [Related]
16. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594
[TBL] [Abstract][Full Text] [Related]
17. Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia.
Gururajan A; Taylor DA; Malone DT
Behav Brain Res; 2011 Sep; 222(2):299-308. PubMed ID: 21458498
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
[TBL] [Abstract][Full Text] [Related]
19. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test.
Moreira FA; Aguiar DC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1466-71. PubMed ID: 16876926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
